Genemind Biosciences obtains tens of millions of yuan in A+ round of financing

Genemind Biosciences has obtained tens of millions of yuan in A+ round of financing from Jinsheng Capital and other institutions. According to Genemind Biosciences, proceeds of this round of financing will be mainly used to promote the clinical application of its third-generation gene sequencing platform GenoCare.

Genemind Biosciences has obtained tens of millions of yuan in A+ round of financing from Jinsheng Capital and other institutions. According to Genemind Biosciences, proceeds of this round of financing will be mainly used to promote the clinical application of its third-generation gene sequencing platform GenoCare.

Genemind Biosciences was founded in 2012, and is mainly committed to the R&D and manufacturing of upstream technology products in the gene industry, such as gene sequencers and supporting reagents. As a pioneer in the domestic third-generation gene sequencing platform, the company’s core technology is single-molecule fluorescence sequencing.

Compared with second-generation sequencing, single-molecule sequencing does not require PCR amplification, and the sequence information to be tested can be read directly through the synthesis reaction with the original DNA or RNA template. Sensitivity also greatly simplifies the detection process and reduces the amount of reagents, which can reduce the cost of the whole process sequencing and acquire advantages in clinical application scenarios.

Genemind Biosciences has more than 180 domestic and foreign patent licenses and applications and 17 computer software copyrights. It has relatively complete intellectual property protection in China, the United States and Europe. Based on these solid research and development foundations, the company expects that its unique GenoCare platform will experience a process of accumulating steadily and wait for a moment to shine in China and the global market, and win a place for domestic sequencers in the industry monopolized by foreign brands.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/05/genemind-biosciences-obtains-tens-of-millions-of-yuan-in-a-round-of-financing/.

Leave a Reply

Please Login to Comment